Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Roitberg, Felipe"'
Autor:
Steinberg J; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia., Hughes S; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia., Hui H; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia., Allsop MJ; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK., Egger S; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia., David M; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia.; School of Medicine and Dentistry, Griffith University, Gold Coast, Australia., Caruana M; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia., Coxeter P; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia., Carle C; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia., Onyeka T; Department of Anaesthesia/Pain & Palliative Care Unit, College of Medicine, University of Nigeria, Ituku-Ozalla Campus, Enugu, Nigeria.; IVAN Research Institute, Enugu, Nigeria., Rewais I; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia., Monroy Iglesias MJ; Translational Oncology and Urology Research (TOUR), Centre for Cancer, Society, and Public Health, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Vives N; Cancer Screening Unit, Institut Català d'Oncologia (ICO), Early Detection of Cancer Group, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.; Ciber Salud Pública (CIBERESP), Instituto Salud Carlos III, Madrid, Spain., Wei F; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer, Lyon, France., Abila DB; Makerere University College of Health Sciences, Kampala, Uganda., Carreras G; Oncologic Network, Prevention and Research Institute (ISPRO), Florence, Italy., Santero M; Iberoamerican Cochrane Centre, IIB Sant Pau-Servei d'Epidemiologia Clínica i Salut Pública, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., O'Dowd EL; Department of Respiratory Medicine, Nottingham University Hospitals NHS Trust, Nottingham, UK., Lui G; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia., Tolani MA; Department of Surgery, Ahmadu Bello University, Zaria, Nigeria., Mullooly M; School of Population Health, RCSI University of Medicine and Health Sciences, Dublin, Ireland., Lee SF; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore.; Department of Clinical Oncology, Tuen Mun Hospital, New Territories West Cluster, Hospital Authority, Hong Kong, China., Landy R; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA., Hanley SJB; Department of Academic Primary Care, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland.; Center for Environmental and Health Sciences, Hokkaido University, Sapporo, Japan., Binefa G; Cancer Screening Unit, Cancer Prevention and Control Program, Catalan Institute of Oncology, Hospitalet de Llobregat, Barcelona, Spain.; Early Detection of Cancer Research Group, EPIBELL Programme, Bellvitge Biomedical Research Institute, Hospitalet de Llobregat, Barcelona, Spain., McShane CM; Centre for Public Health, Queen's University Belfast, Institute of Clinical Sciences Block B, Royal Victoria Hospital, Belfast, Northern Ireland., Gizaw M; Department of Preventive Medicine, School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.; Institute for Medical Epidemiology, Biometrics and Informatics, Martin Luther University of Halle-Wittenberg, Halle, Germany.; NCD Working Group, School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia., Selvamuthu P; Chennai Antiviral Research and Treatment Center and Clinical Research Site (CART CRS), Infectious Diseases Medical Center, Voluntary Health Services, Chennai, India., Boukheris H; University Abderrahmane Mira of Bejaia, School of Medicine, Bejaia, Algeria.; Department of Epidemiology and Preventive Medicine, University Hospital of Bejaia, Bejaia, Algeria., Nakaganda A; Department of Cancer Epidemiology and Clinical Trials, Uganda Cancer Institute, Kampala, Uganda., Ergin I; Department of Public Health, Faculty of Medicine, Ege University, Bornova, Turkey., Moraes FY; Department of Oncology, Queen's University, Kingston, Ontario, Canada., Timilshina N; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada., Kumar A; Department of Anatomy, All India Institute of Medical Sciences-Patna, Patna, India., Vale DB; Department of Obstetrics and Gynecology, University of Campinas (UNICAMP), Campinas, Brazil., Molina-Barceló A; Cancer and Public Health Research Unit, Biomedical Research Foundation FISABIO, Valencia, Spain., Force LM; Department of Health Metrics Sciences, Division of Hematology/Oncology, University of Washington, Seattle, Washington, USA.; Department of Pediatrics, Division of Hematology/Oncology, University of Washington, Seattle, Washington, USA., Campbell DJ; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia., Wang Y; School of Public Health, University of Sydney, Sydney, New South Wales, Australia., Wan F; School of Public Health, University of Sydney, Sydney, New South Wales, Australia., Baker AL; School of Public Health, University of Sydney, Sydney, New South Wales, Australia., Singh R; School of Public Health, University of Sydney, Sydney, New South Wales, Australia., Salam RA; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia., Yuill S; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia.; School of Public Health, University of Sydney, Sydney, New South Wales, Australia., Shah R; Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France., Lansdorp-Vogelaar I; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Yusuf A; Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore & Peshawar, Lahore, Pakistan., Aggarwal A; Department of Health Services Research and Policy, School of Hygiene and Tropical Medicine, King's College London, London, UK.; Department of Oncology, Guy's & St Thomas NHS Trust, London, UK., Murillo R; Centro Javeriano De Oncologia - Hospital Universitario San Ignacio, Bogotá, Colombia.; Pontificia Universidad Javeriana, Bogotá, Colombia., Torode JS; Institute of Cancer Policy, King's College London, London, UK.; Research Oncology, Bermondsey Wing, Guy's Hospital, London, UK., Kliewer EV; Department of Cancer Control Research, BC Cancer Research Institute, Vancouver, British Columbia, Canada., Bray F; Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France., Chan KKW; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; Canadian Centre for Applied Research in Cancer Control, Vancouver, British Columbia, Canada., Peacock S; Department of Cancer Control Research, BC Cancer Research Institute, Vancouver, British Columbia, Canada.; Canadian Centre for Applied Research in Cancer Control, Vancouver, British Columbia, Canada.; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada., Hanna TP; Division of Cancer Care and Epidemiology, Cancer Research Institute at Queen's University, Kingston, Ontario, Canada.; Department of Oncology and Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada., Ginsburg O; Center for Global Health, National Cancer Institute, Rockville, Maryland, USA., Van Hemelrijck M; Translational Oncology and Urology Research (TOUR), Centre for Cancer, Society, and Public Health, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Sullivan R; Institute of Cancer Policy, King's College London, London, UK., Roitberg F; Department of Non-Communicable Diseases, World Health Organisation, Geneva, Switzerland.; Hospital Sírio Libanês, São Paulo, Brazil.; Rede Ebserh, Rede Brasileira de Serviços Hospitalares, Brasília, Brazil., Ilbawi AM; Hospital Sírio Libanês, São Paulo, Brazil., Soerjomataram I; Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France., Canfell K; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia.
Publikováno v:
International journal of cancer [Int J Cancer] 2024 Apr 15; Vol. 154 (8), pp. 1394-1412. Date of Electronic Publication: 2023 Dec 11.
Autor:
Veljkovikj I; Division Programme of Action for Cancer Therapy (PACT), International Atomic Energy Agency (IAEA) Vienna, Austria. Electronic address: I.veljkovik@iaea.org., Ilbawi AM; World Health Organization, Geneva, Switzerland., Roitberg F; World Health Organization, Geneva, Switzerland., Luciani S; Noncommunicable Diseases, Violence and Injury Prevention, Pan-American Health Organization, World Health Organization, Washington, DC, USA., Barango P; Noncommunicable Diseases, Inter-country Support Team for East and Southern Africa, Regional Office for Africa, World Health Organization, Brazzaville, Republic of Congo., Corbex M; Noncommunicable Diseases, Regional Office for Europe, World Health Organization, Copenhagen, Denmark., Dorji G; Noncommunicable Diseases and Mental Health, Country Office Nepal, World Health Organization, Lalitpur, Nepal., Gunawardena N; Noncommunicable Diseases, Country Office Sri Lanka, World Health Organization, Colombo, Sri Lanka., Johnson S; Knowledge, Advocacy, and Policy, Union for International Cancer Control (UICC), Geneva, Switzerland., Juric A; Division Programme of Action for Cancer Therapy (PACT), International Atomic Energy Agency (IAEA) Vienna, Austria., Siewert K; Division Programme of Action for Cancer Therapy (PACT), International Atomic Energy Agency (IAEA) Vienna, Austria., Saporiti G; Division Programme of Action for Cancer Therapy (PACT), International Atomic Energy Agency (IAEA) Vienna, Austria., Nobile M; Division Programme of Action for Cancer Therapy (PACT), International Atomic Energy Agency (IAEA) Vienna, Austria., Sauvaget C; Early Detection Prevention and Infections Branch, International Agency for Research on Cancer (IARC), Lyon, France., Vidanapathirana J; National Cancer Control Programme, Ministry of Health, Colombo, Sri Lanka., Wright B; Health Systems Strengthening Programme, Ministry of Health and Wellness, Kingston, Jamaica., Lishimpi K; Department of Cancer Control Services, Ministry of Health, Lusaka, Zambia., Kaidarova D; Kazakh Research Institute of Oncology and Radiology, Almaty, Kazakhstan., Pomata A; National Cancer Control Programme, Ministry of Health, Asunción, Paraguay., Malick A; Division of Noncommunicable Diseases, Ministry of Health, Dakar, Senegal., Dangou JM; Noncommunicable Diseases Management, Regional Office for Africa, World Health Organization, Brazzaville, Republic of Congo., Abdel-Wahab M; Division of Human Health (NAHU), International Atomic Energy Agency (IAEA) Vienna, Austria., Weiderpass E; International Agency for Research on Cancer (IARC), Lyon, France., Mikkelsen B; Department of Noncommunicable Diseases, World Health Organization, Geneva, Switzerland., Stevens LM; Division Programme of Action for Cancer Therapy (PACT), International Atomic Energy Agency (IAEA) Vienna, Austria.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2022 Oct; Vol. 23 (10), pp. e459-e468.
Autor:
Trapani D; European Institute of Oncology, IRCCS, 20141 Milan, Italy.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Pharmaceutical Sciences, Università Del Piemonte Orientale, 28100 Novara, Italy., Tay-Teo K; Department of Health Products Policy and Standards, World Health Organization, 1211 Geneva, Switzerland., Tesch ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Roitberg F; Medical Oncology Service, Hospital Sírio-Libanês, São Paulo 01308-050, Brazil., Sengar M; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai 400094, India., Altuna SC; Oncomédica C. A., Caracas 1040, Venezuela., Hassett MJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Genazzani AA; Department of Pharmaceutical Sciences, Università Del Piemonte Orientale, 28100 Novara, Italy., Kesselheim AS; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 1620, USA., Curigliano G; European Institute of Oncology, IRCCS, 20141 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Aug 16; Vol. 29 (8), pp. 5774-5791. Date of Electronic Publication: 2022 Aug 16.
Autor:
Sengar M; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Fundytus A; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Canada.; Department of Oncology, Queen's University, Kingston, Canada., Hopman W; Department of Public Health Sciences, Queen's University, Kingston, Canada., Pramesh CS; Department of Surgical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Radhakrishnan V; Department of Medical Oncology, Cancer Institute (W.I.A.), Chennai, India., Ganesan P; Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India., Mathew A; Malankara Orthodox Syrian Church Medical College, Kolenchery, India., Lombe D; Cancer Diseases Hospital, Lusaka, Zambia., Jalink M; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Canada.; Department of Public Health Sciences, Queen's University, Kingston, Canada., Gyawali B; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Canada.; Department of Oncology, Queen's University, Kingston, Canada.; Department of Public Health Sciences, Queen's University, Kingston, Canada., Trapani D; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Roitberg F; Department of Noncommunicable Diseases, World Health Organization, Geneva, Switzerland., De Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Moja L; Department of Health Products Policy and Standards, World Health Organization, Geneva, Switzerland., Ilbawi A; Department of Health Products Policy and Standards, World Health Organization, Geneva, Switzerland., Sullivan R; Institute of Cancer Policy, King's College London, London, United Kingdom., Booth CM; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Canada.; Department of Oncology, Queen's University, Kingston, Canada.; Department of Public Health Sciences, Queen's University, Kingston, Canada.
Publikováno v:
JCO global oncology [JCO Glob Oncol] 2022 Jul; Vol. 8, pp. e2200060.
Autor:
Denburg AE; Division of Haematology/Oncology, Department of Paediatrics, University of Toronto, Toronto, Canada.; Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada., Fundytus A; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Canada., Khan MS; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, Al Madinah Al Munawarrah, Saudi Arabia., Howard SC; University of Tennessee Health Science Center, Memphis, TN., Antillon-Klussmann F; School of Medicine, Francisco Marroquin University, Guatemala, Guatemala.; Unidad Nacional de Oncologia Paediatrica, Guatemala, Guatemala., Sengar M; Department of Medical Oncology, Tata Memorial Centre, Mumbai, India., Lombe D; Department of Radiation Oncology, MidCentral District Health Board, Palmerston North, New Zealand., Hopman W; Department of Public Health Sciences, Queen's University, Kingston, Canada., Jalink M; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Canada.; Department of Public Health Sciences, Queen's University, Kingston, Canada., Gyawali B; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Canada.; Department of Public Health Sciences, Queen's University, Kingston, Canada.; Department of Oncology, Queen's University, Kingston, Canada., Trapani D; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Roitberg F; Department of Noncommunicable Diseases, World Health Organization, Geneva, Switzerland., De Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Moja L; Department of Health Products Policy and Standards, World Health Organization, Geneva, Switzerland., Ilbawi A; Department of Health Products Policy and Standards, World Health Organization, Geneva, Switzerland., Sullivan R; Institute of Cancer Policy, King's College London, London, United Kingdom., Booth CM; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Canada.; Department of Public Health Sciences, Queen's University, Kingston, Canada.; Department of Oncology, Queen's University, Kingston, Canada.
Publikováno v:
JCO global oncology [JCO Glob Oncol] 2022 Jun; Vol. 8, pp. e2200034.
Autor:
Munisamy M; National Cancer Society of Malaysia, Kuala Lumpur, Malaysia.; Union for International Cancer Control (UICC) Young Leaders Programme 2019/2020, Geneva, Switzerland., Ndoh K; Union for International Cancer Control (UICC) Young Leaders Programme 2019/2020, Geneva, Switzerland.; Department of Global Health, University of Washington, Seattle, WA., Abdelbadee A; Union for International Cancer Control (UICC) Young Leaders Programme 2019/2020, Geneva, Switzerland.; Department of Obstetrics and Gynecology, Faculty of Medicine, Assiut University, Assiut, Egypt., Espejo I; Union for International Cancer Control (UICC) Young Leaders Programme 2019/2020, Geneva, Switzerland.; Fundacion Aladina, Madrid, Spain., Manjuh F; Union for International Cancer Control (UICC) Young Leaders Programme 2019/2020, Geneva, Switzerland.; Women's Health Program, Cameroon Baptist Convention Health Services, Cameroon., Tamas A; Union for International Cancer Control (UICC) Young Leaders Programme 2019/2020, Geneva, Switzerland.; European Network for Smoking and Tobacco Prevention., Salako O; Union for International Cancer Control (UICC) Young Leaders Programme 2019/2020, Geneva, Switzerland.; Department of Radiation Biology, Radiotherapy and Radiodiagnosis, College of Medicine, University of Lagos, Nigeria.; Sebeccly Cancer Care, Lagos, Nigeria.; Oncopadi Digital Clinic, Lagos, Nigeria., Roitberg F; Union for International Cancer Control (UICC) Young Leaders Programme 2019/2020, Geneva, Switzerland.; Instituto do Câncer do Estado de São Paulo, Sao Paulo, Brazil.; European Society for Medical Oncology (ESMO), Lugano, Switzerland.
Publikováno v:
JCO global oncology [JCO Glob Oncol] 2021 Jul; Vol. 7, pp. 1194-1198.
Autor:
Srivastava A; Department of Medicine, Queen's University, Kingston, ON, Canada., Jalink M; Department of Oncology, Queen's University, Kingston, ON, Canada., de Moraes FY; Department of Oncology, Queen's University, Kingston, ON, Canada., Booth CM; Department of Oncology, Queen's University, Kingston, ON, Canada., Berry SR; Department of Oncology, Queen's University, Kingston, ON, Canada., Rubagumya F; Department of Oncology, Rwanda Military Hospital, Kigali, Rwanda., Roitberg F; Department of Oncology, University of Sao Paulo, Sao Paulo, Brazil., Sengar M; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National University, Mumbai, India., Hammad N; Department of Oncology, Queen's University, Kingston, ON, Canada.
Publikováno v:
JCO global oncology [JCO Glob Oncol] 2021 Jun; Vol. 7, pp. 925-933.
Autor:
Pacheco RL; Centro Universitário São Camilo (CUSC), São Paulo, Brazil.; Centre of Health Technology Assessment, Hospital Sírio-Libanês, São Paulo, Brazil.; Oxford-Brazil EBM Alliance, Petropolis, Brazil., Martimbianco ALC; Centro Universitário São Camilo (CUSC), São Paulo, Brazil.; Oxford-Brazil EBM Alliance, Petropolis, Brazil.; Programa de Pós-graduação em Saúde e Meio Ambiente, Universidade Metropolitana de Santos (UNIMES), Santos, Brazil., Roitberg F; Instituto do Câncer do Estado de São Paulo/HCFMUSP, World Health Organization (WHO), São Paulo, Brazil.; Department of Noncommunicable Diseases, World Health Organization (WHO) Headquarters, Geneva, Switzerland.; European Society for Medical Oncology (ESMO), Lugano, Switzerland., Ilbawi A; Department of Noncommunicable Diseases, World Health Organization (WHO) Headquarters, Geneva, Switzerland., Riera R; Centre of Health Technology Assessment, Hospital Sírio-Libanês, São Paulo, Brazil.; Oxford-Brazil EBM Alliance, Petropolis, Brazil.; Discipline of Evidence-Based Medicine, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
Publikováno v:
JCO global oncology [JCO Glob Oncol] 2021 Feb; Vol. 7, pp. 342-352.
Autor:
Riera R; Centre of Health Technology Assessment, Hospital Sírio-Libanês, São Paulo, Brazil.; Discipline of Evidence-Based Medicine, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (Unifesp), São Paulo, Brazil.; Oxford-Brazil EBM Alliance, Petrópolis, Brazil., Bagattini ÂM; Centre of Health Technology Assessment, Hospital Sírio-Libanês, São Paulo, Brazil., Pacheco RL; Centre of Health Technology Assessment, Hospital Sírio-Libanês, São Paulo, Brazil.; Discipline of Evidence-Based Medicine, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (Unifesp), São Paulo, Brazil.; Oxford-Brazil EBM Alliance, Petrópolis, Brazil.; Centro Universitário São Camilo, São Paulo, Brazil., Pachito DV; Centre of Health Technology Assessment, Hospital Sírio-Libanês, São Paulo, Brazil., Roitberg F; Instituto do Câncer do Estado de São Paulo/HCFMUSP, São Paulo, Brazil.; Department of Noncommunicable Diseases, World Health Organization (WHO), Geneva, Switzerland.; European Society for Medical Oncology (ESMO), Lugano, Switzerland., Ilbawi A; Department of Noncommunicable Diseases, World Health Organization (WHO), Geneva, Switzerland.
Publikováno v:
JCO global oncology [JCO Glob Oncol] 2021 Feb; Vol. 7, pp. 311-323.
Autor:
Aguiar PN Jr; Faculdade de Medicina do ABC, Santo André, Brazil; Américas Centro de Oncologia Integrado, São Paulo, Brazil., Adashek JJ; College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, USA., Roitberg F; Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil., Noia Barreto CM; Division of Pathology, MD Anderson Cancer Center at the University of Texas, Houston, TX, USA., Del Giglio A; Centro de Estudos e Pesquisa de Hematologia e Oncologia, Santo André, Brazil., Lopes GL Jr; Sylvester Comprehensive Cancer Center at the University of Miami, Miami, FL, USA. Electronic address: glopes.md@gmail.com.
Publikováno v:
Value in health regional issues [Value Health Reg Issues] 2019 Dec; Vol. 20, pp. 47-50. Date of Electronic Publication: 2019 Mar 09.